Screener
Spyre Therapeutics, Inc. SYRE Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Spyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001636282-26-000050
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Marketable securities | 644,282 | 670,812 |
| Prepaid expenses and other current assets | 22,486 | 21,248 |
| Total current assets | 763,953 | 777,781 |
| TOTAL ASSETS | $763,953 | $777,781 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $5,692 | $8,904 |
| CVR liability | 50,260 | 22,820 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Spyre Therapeutics, Inc.'s total assets?
- Spyre Therapeutics, Inc. (SYRE) reported total assets of $763.95M in Q1 2026.
- How has Spyre Therapeutics, Inc.'s total assets changed year-over-year?
- Spyre Therapeutics, Inc.'s total assets increased by 34.1% year-over-year, from $569.78M to $763.95M.
- What is the long-term trend for Spyre Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Spyre Therapeutics, Inc.'s total assets has grown at a 36.9% compound annual growth rate (CAGR), from $161.62M to $777.78M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Spyre Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude